Your search returned 115 results.

Results
	101.	Characterization of the binding of urokinase-type plasminogen activator to the asialoglycoprotein receptor. [electronic resource] by Rijken, D C van der Kaaden, M E Groeneveld, E Barrett-Bergshoeff, M M van Berkel, Th J C Kuiper, J Producer: 20030818 In: Thrombosis and haemostasis vol. 88 Availability: No items available. Save to lists Add to cart (remove)
	102.	Binding and retention of polycationic peptides and dendrimers in the vascular wall. [electronic resource] by Sakharov, D V Jie, A F H Filippov, D V Bekkers, M E A van Boom, J H Rijken, D C Producer: 20030418 In: FEBS letters vol. 537 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	103.	Simultaneous detection of endogenous lectins and their binding capacity at the single-cell level--a technical note. [electronic resource] by Fronková, V Holíková, Z Liu, F T Homolka, J Rijken, D C André, S Bovin, N V Smetana, K Gabius, H J Producer: 20000424 In: Folia biologica vol. 45 Availability: No items available. Save to lists Add to cart (remove)
	104.	Increased plasminogen activator inhibition levels in malignancy. [electronic resource] by de Jong, E Knot, E A Piket, D Iburg, A H Rijken, D C Veenhof, K H Dooijewaard, G ten Cate, J W Producer: 19870810 In: Thrombosis and haemostasis vol. 57 Availability: No items available. Save to lists Add to cart (remove)
	105.	The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. [electronic resource] by Kluft, C Verheijen, J H Jie, A F Rijken, D C Preston, F E Sue-Ling, H M Jespersen, J Aasen, A O Producer: 19860121 In: Scandinavian journal of clinical and laboratory investigation vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	106.	Evidence for an enhanced fibrinolytic capacity in cirrhosis as measured with two different global fibrinolysis tests. [electronic resource] by Rijken, D C Kock, E L Guimarães, A H C Talens, S Darwish Murad, S Janssen, H L A Leebeek, F W G Producer: 20130228 In: Journal of thrombosis and haemostasis : JTH vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	107.	Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. [electronic resource] by Biessen, E A Noorman, F van Teijlingen, M E Kuiper, J Barrett-Bergshoeff, M Bijsterbosch, M K Rijken, D C van Berkel, T J Producer: 19961230 In: The Journal of biological chemistry vol. 271 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	108.	Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. [electronic resource] by Biessen, E A van Teijlingen, M Vietsch, H Barrett-Bergshoeff, M M Bijsterbosch, M K Rijken, D C van Berkel, T J Kuiper, J Producer: 19970204 In: Circulation vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	109.	Binding of carboxypeptidase N to fibrinogen and fibrin. [electronic resource] by Talens, S Lebbink, J H G Malfliet, J J M C Demmers, J A A Uitte de Willige, S Leebeek, F W G Rijken, D C Producer: 20130305 In: Biochemical and biophysical research communications vol. 427 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	110.	High functional levels of thrombin-activatable fibrinolysis inhibitor are associated with an increased risk of first ischemic stroke. [electronic resource] by Leebeek, F W G Goor, M P J Guimaraes, A H C Brouwers, G-J Maat, M P M Dippel, D W J Rijken, D C Producer: 20051214 In: Journal of thrombosis and haemostasis : JTH vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	111.	Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children. [electronic resource] by Emonts, M de Bruijne, E L E Guimarães, A H C Declerck, P J Leebeek, F W G de Maat, M P M Rijken, D C Hazelzet, J A Gils, A Producer: 20080501 In: Journal of thrombosis and haemostasis : JTH vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	112.	The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study. [electronic resource] by de Bruijne, E L E Gils, A Guimarães, A H C Dippel, D W J Deckers, J W van den Meiracker, A H Poldermans, D Rijken, D C Declerck, P J de Maat, M P M Leebeek, F W G Producer: 20090915 In: Journal of thrombosis and haemostasis : JTH vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	113.	Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease. [electronic resource] by De Wee, E M Klaij, K Eikenboom, H C J Van Der Bom, J G Fijnvandraat, K Laros-Van Gorkom, B A P Mauser-Bunschoten, E P Meijer, K Goverde, G Van Der Linden, P W G Rijken, D C Leebeek, F W G Producer: 20120801 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	114.	Plasma levels of plasminogen activator inhibitor-1 and bleeding phenotype in patients with von Willebrand disease. [electronic resource] by Abdul, S Boender, J Malfliet, J J M C Eikenboom, J Fijn van Draat, K Mauser-Bunschoten, E P Meijer, K de Meris, J Laros-van Gorkom, B A P van der Bom, J G Leebeek, F W G Rijken, D C Uitte de Willige, S Producer: 20171129 In: Haemophilia : the official journal of the World Federation of Hemophilia vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	115.	The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy. [electronic resource] by van der Pas, R de Bruin, C Leebeek, F W G de Maat, M P M Rijken, D C Pereira, A M Romijn, J A Netea-Maier, R T Hermus, A R Zelissen, P M J de Jong, F H van der Lely, A J de Herder, W W Lamberts, S W J Hofland, L J Feelders, R A Producer: 20120611 In: The Journal of clinical endocrinology and metabolism vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6